Trader consensus prices "No" at 84% implied probability for a new WHO-designated COVID-19 variant of concern before 2027, driven by sustained high population immunity from vaccines and prior infections that have kept recent SARS-CoV-2 subvariants in check. The past week's wastewater data shows BA.3.2 ("Cicada"), a highly mutated Omicron descendant with immune escape potential, circulating in over 30 U.S. states and 33 countries since late March 2026, yet test positivity remains low at 3.4% with no surge in hospitalizations or deaths. ECDC and WHO track it as a variant under monitoring without VOC elevation—requiring clear evidence of heightened transmissibility, severity, or treatment failure—amid declining global genomic surveillance. A sharp rise in virulence could still prompt reclassification by year-end.